Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials
Ann Rheum Dis 2017;76:1253-1262. DOI 10.1136/annrheumdis-2016-210457
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Ann Rheum Dis 2017;76:1253-1262. DOI 10.1136/annrheumdis-2016-210457
Ann Rheum Dis Published Online First: 7 April 2017. Doi 10.1136/annrheumdis-20160210561
Nature Reviews Rheumatology 2017;13:234–43
Arthritis Rheumatol 2016;68:2867–77
Arthritis Rheumatol 2016;68:2857–66
Arthritis Rheumatol DOI 10.1002/art.40054. Accepted article.
J Rheumatol 2017;44:2. DOI 10.3899/jrheum.160287.
Arthritis Rheumatol 2016. DOI:10.1002/art.39944.
Ann Rheum Dis 2016. DOI 10.1136/annrheumdis-2016-210310
Arthritis Rheumatol 2016. DOI 10.1002/art.39953. Accepted article